JP2006503617A - System and method for trend analysis in sedation and analgesia systems - Google Patents

System and method for trend analysis in sedation and analgesia systems Download PDF

Info

Publication number
JP2006503617A
JP2006503617A JP2004541700A JP2004541700A JP2006503617A JP 2006503617 A JP2006503617 A JP 2006503617A JP 2004541700 A JP2004541700 A JP 2004541700A JP 2004541700 A JP2004541700 A JP 2004541700A JP 2006503617 A JP2006503617 A JP 2006503617A
Authority
JP
Japan
Prior art keywords
patient
sedation
trend
analgesia
trend analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004541700A
Other languages
Japanese (ja)
Other versions
JP2006503617A5 (en
Inventor
ヒックル、ランドール・エス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scott Laboratories Inc
Original Assignee
Scott Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scott Laboratories Inc filed Critical Scott Laboratories Inc
Publication of JP2006503617A publication Critical patent/JP2006503617A/en
Publication of JP2006503617A5 publication Critical patent/JP2006503617A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/024Measuring pulse rate or heart rate
    • A61B5/0245Measuring pulse rate or heart rate by using sensing means generating electric signals, i.e. ECG signals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/024Measuring pulse rate or heart rate
    • A61B5/02416Measuring pulse rate or heart rate using photoplethysmograph signals, e.g. generated by infrared radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4821Determining level or depth of anaesthesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4836Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0051Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes with alarm devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/01Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes specially adapted for anaesthetising
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/021Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
    • A61M16/022Control means therefor
    • A61M16/024Control means therefor including calculation means, e.g. using a processor
    • A61M16/026Control means therefor including calculation means, e.g. using a processor specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/14Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A61M16/16Devices to humidify the respiration air
    • A61M16/161Devices to humidify the respiration air with means for measuring the humidity
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/0205Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
    • A61B5/02055Simultaneously evaluating both cardiovascular condition and temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0027Accessories therefor, e.g. sensors, vibrators, negative pressure pressure meter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0036Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the breathing tube and used in both inspiratory and expiratory phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/1005Preparation of respiratory gases or vapours with O2 features or with parameter measurement
    • A61M2016/102Measuring a parameter of the content of the delivered gas
    • A61M2016/1035Measuring a parameter of the content of the delivered gas the anaesthetic agent concentration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/17General characteristics of the apparatus with redundant control systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3368Temperature
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/50General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502User interfaces, e.g. screens or keyboards
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/581Means for facilitating use, e.g. by people with impaired vision by audible feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/58Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/04Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • A61M2230/06Heartbeat rate only
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/205Blood composition characteristics partial oxygen pressure (P-O2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/30Blood pressure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/40Respiratory characteristics
    • A61M2230/43Composition of exhalation
    • A61M2230/432Composition of exhalation partial CO2 pressure (P-CO2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Signal Processing (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

本発明は、データアーティファクトによる誤検出警報応答の確率を低減するように、単一患者パラメータに関連する単一モニタからデータを収集することができる鎮静・鎮痛システムを含む。本発明はまた、切迫したよくない患者の状態を検出することができ、かかる状態をよくない患者の状態が実際に発現する前に検出することができる、モニタリングシステムを含む。本発明はさらに、鎮静・鎮痛システムに傾向分析を組み込む方法を含む。The present invention includes a sedation and analgesia system that can collect data from a single monitor associated with a single patient parameter to reduce the probability of a false positive alarm response due to data artifacts. The present invention also includes a monitoring system that can detect an impending bad patient condition and can detect such a condition before the bad patient condition actually develops. The present invention further includes a method of incorporating trend analysis into a sedation and analgesia system.

Description

[発明の背景]
本発明は、概して、傾向分析に関し、特に、鎮静・鎮痛システムのモニタリング、処理および出力機能に組み込まれた傾向分析に関する。
[Background of the invention]
The present invention relates generally to trend analysis, and more particularly to trend analysis built into the monitoring, processing and output functions of sedation and analgesia systems.

[関連出願の相互参照]
この出願は、米国特許法第119(e)条(35 U.S.C. §119(e))に基づき、参照により本明細書に援用される2002年10月3日に出願された「Systems and Methods for Providing Trend Analysis in a Sedation and Analgesia System」と題する米国仮特許出願第60/415,524号に対する優先権を主張する。
[Cross-reference of related applications]
This application is based on 35 U.S.C. 119 (e) (35 USC §119 (e)) and is filed on Oct. 3, 2002, which is incorporated herein by reference. Claims priority to US Provisional Patent Application No. 60 / 415,524 entitled “Trend Analysis in a Sedation and Analgesia System”.

[連邦政府による資金提供を受けた研究開発の記載]
適用なし
[Description of research and development funded by the federal government]
Not applicable

[「マイクロフィッシュ付録」への参照]
適用なし
[Reference to “Microfiche Appendix”]
Not applicable

[関連技術の説明]
苦痛、不快、もしくは恐ろしい(不安を駆り立てる)医療または外科的処置を受けている患者に対し、鎮静剤、鎮痛剤および/または記憶消失剤を、資格を有する麻酔担当者がいてもいなくても過剰投薬の危険性を低減する方法で安全に受容する手段を提供する、鎮静・鎮痛システムが開発されてきた。技術の著しい進歩により、鎮静・鎮痛システムを、病院および外来環境で使用するために安全なものとすることができ、たとえば、C.R.N.A.、訓練を受けた医師または他の訓練を受けた技師等の訓練を受けた麻酔医以外の人が操作することができる。鎮静・鎮痛システムは、安全かつ効果的な鎮静および鎮痛が、恐怖および苦痛の影響を実質的に軽減することができるすべての処置に対し、麻酔担当者を手配することができない、開業医のニーズを満たすために役立ってきた。これらの目的に向けられた鎮静・鎮痛システムの出現により、これらの人々に対し、麻酔器の操作に必要な認識的かつ手作業による作業負荷を低減する患者モニタリングシステムに統合された薬剤送達システムが提供されるが、それでも臨床医は依然として患者の管理の中心に居続ける。「臨床医が一番知っている」という原理に従って、臨床医には、最終的な判断を行う責任が依然として与えられている。この高度な技術により、鎮静・鎮痛システムを、患者に対し鎮静、記憶消失および/または鎮痛の費用効率がよく容易に利用可能な手段を提供して、麻酔担当者がいなくても全身麻酔より低い薬物濃度効果で操作することができる。
[Description of related technology]
Excessive use of sedatives, analgesics and / or amnesia for patients undergoing painful, uncomfortable, or terrible (rising anxiety) medical or surgical procedures, with or without a qualified anesthetist Sedation and analgesia systems have been developed that provide a safe means of accepting in a way that reduces the risk of medication. Significant advances in technology can make sedation and analgesia systems safe for use in hospitals and outpatient settings, for example C.I. R. N. A. A person other than a trained anesthesiologist, such as a trained doctor or other trained technician, can operate. The sedation / analgesic system addresses the needs of practitioners, where safe and effective sedation and analgesia cannot arrange anesthesia personnel for all procedures that can substantially reduce the effects of fear and pain. Has helped to meet. With the advent of sedation and analgesia systems aimed at these purposes, drug delivery systems integrated into patient monitoring systems that reduce the cognitive and manual workload required for anesthesia machine operation for these people Although provided, clinicians still remain at the center of patient management. In accordance with the principle “the clinician knows best”, the clinician is still given the responsibility to make a final decision. This advanced technology makes the sedation / analgesic system lower than general anesthesia even without anesthesia personnel, providing the patient with a cost-effective and easily accessible means of sedation, memory loss and / or analgesia Can be manipulated by drug concentration effect.

鎮静・鎮痛システムの例は、1999年6月3日に出願され全体として参照により本明細書に援用される米国特許出願第09/324,759号に述べられている。この鎮静・鎮痛システムは、1つまたは複数の患者の生理学的状態を電子的にモニタしながら、たとえば、1つまたは複数の鎮静剤、鎮痛剤および/または記憶消失剤の送達と、気道陽圧の送出と、薬剤送達の減少または増加と、酸素の送出と、たとえばオピオイド拮抗薬への薬剤の変更と、患者モニタからのさらなる情報の要求と、警報のトリガと、を、電子的に統合する。一形態では、米国特許出願第09/324,759号のシステムは、患者およびシステムの状態を反映する格納されたデータ定義パラメータの1つまたは複数のセットを使用し、そのパラメータは、ソフトウェアを通して、薬剤送達を控えめに管理しかつ意識のある患者の生命徴候および他の生理学的状態に関連する安全な費用効率のよい最適化された値に相関させるために、アクセスされる。   An example of a sedation and analgesia system is described in US patent application Ser. No. 09 / 324,759, filed Jun. 3, 1999 and incorporated herein by reference in its entirety. This sedation / analgesic system can be used to electronically monitor the physiological state of one or more patients while delivering, for example, one or more sedatives, analgesics and / or memory loss agents, and positive airway pressure. Electronically integrates delivery of drugs, decrease or increase in drug delivery, delivery of oxygen, drug changes to eg opioid antagonists, requests for further information from patient monitors, and alarm triggers . In one form, the system of US patent application Ser. No. 09 / 324,759 uses one or more sets of stored data definition parameters reflecting patient and system status, which parameters are Accessed to conservatively manage drug delivery and correlate with safe cost-effective optimized values related to conscious patient vital signs and other physiological conditions.

偽の(spurious)モニタデータまたは他の要因により、鎮静・鎮痛システムは、危険な可能性がある処置を行い、重大な状況において処置を行わず、または不要に警報を与える可能性がある。たとえば、鎮静・鎮痛システムは、不安定になった心電計(ECG)で患者の心拍数をモニタしている場合がある。鎮静・鎮痛システムは、単一モニタに基づいて、不安定なECGデータが実際には偽である場合、たとえば危険なまでに低い心拍数を示す警報を通知する可能性がある。誤検出警報の頻度が高いことにより、臨床医がいらだつ可能性があり、真の生死にかかわる状態に対してそれほど注意が向けられないことになる可能性がある。   Due to spurious monitor data or other factors, the sedation / analgesic system may take a potentially dangerous action, take no action in critical situations, or give an unnecessary alarm. For example, a sedation / analgesic system may monitor a patient's heart rate with an unstable electrocardiograph (ECG). Based on a single monitor, the sedation / analgesic system may signal an alarm indicating, for example, a dangerously low heart rate if the unstable ECG data is actually false. The high frequency of false alarms can be frustrating to the clinician, and can be less focused on true life-threatening conditions.

一般に、医療機器に組み込まれたモニタリングシステムは、専用のモニタにより所与の患者パラメータをモニタする。そして、モニタされたパラメータに対し、安全データセットを確立し、モニタされたデータが安全範囲外になると、警報応答を開始する。かかるシステムは、ほとんどの真のよくない(adverse)患者の状態が検出される場合に、高感度を提供する可能性があるが、安全データセット外になるデータアーティファクトからもたらされる誤検出警報もまた発生しやすいという可能性もある。さらに、心拍数等の多くの患者パラメータは、切迫したよくない患者の状態の場合、安全データセットの閾値に向かって線形にまたは単調に低下し、よくない患者の状態を示す。既存のモニタリングシステムでは、かかる低下は、一般に、データが安全データセット外になるまで検出されないが、所定の期間にわたって患者の心拍数を見ることにより、患者パラメータが実際に安全データセットから出る数秒前に、よくない患者の事象が切迫していることが明らかである場合がある。データが確立された安全データセット閾値を越えるまで待つことにより、患者がすでによくない状態にある状況において、臨床医が遅れを取り戻そうと奮闘することになる可能性がある。   In general, monitoring systems built into medical devices monitor a given patient parameter with a dedicated monitor. Then, a safety data set is established for the monitored parameter, and when the monitored data is out of the safe range, an alarm response is started. Such a system may provide high sensitivity when most true patient conditions are detected, but false positive alerts resulting from data artifacts that fall outside the safety data set are also There is a possibility that it is likely to occur. In addition, many patient parameters such as heart rate, in the case of an impending bad patient condition, decrease linearly or monotonically towards the threshold of the safety data set, indicating a bad patient condition. In existing monitoring systems, such a drop is generally not detected until the data is out of the safety data set, but by looking at the patient's heart rate over a given period, a few seconds before the patient parameters actually exit the safety data set. In some cases, it is clear that bad patient events are imminent. By waiting for the data to exceed the established safety data set threshold, the clinician may struggle to catch up in the situation where the patient is already in poor condition.

[発明の概要]
本発明は、データアーティファクトによる誤検出警報応答の確率を低減するように、単一患者パラメータに関連する単一モニタからデータを収集することができる鎮静・鎮痛システムを含む。本発明はまた、切迫したよくない患者の状態を検出することができ、かかる状態をよくない患者の状態が実際に発生する前に検出することができる、モニタリングシステムも含む。
[Summary of Invention]
The present invention includes a sedation and analgesia system that can collect data from a single monitor associated with a single patient parameter to reduce the probability of a false positive alarm response due to data artifacts. The present invention also includes a monitoring system that can detect an impending bad patient condition and detect such a condition before the bad patient condition actually occurs.

本発明はまた、鎮静・鎮痛システムに傾向分析を組み込む方法も含む。一実施形態において、かかる方法は、単一患者パラメータをモニタする患者モニタを提供すること、およびそのモニタにより患者をモニタすることを含み、それにより、モニタから収集されたデータを鎮静・鎮痛システムのコントローラに送信する。本方法は、鎮静・鎮痛システムのアルゴリズムに傾向を入力することか、または傾向を分析することをさらに含む。最後に、本方法は、傾向分析に基づいて適当な処置を開始することをさらに含む。   The present invention also includes a method of incorporating trend analysis into a sedation and analgesia system. In one embodiment, such a method includes providing a patient monitor that monitors a single patient parameter, and monitoring the patient with the monitor, thereby collecting data collected from the monitor of the sedation and analgesia system. Send to controller. The method further includes inputting a trend into the sedation and analgesia system algorithm or analyzing the trend. Finally, the method further includes initiating appropriate treatment based on the trend analysis.

[発明の詳細な説明]
図1は、ユーザインタフェース12、ソフトウェア制御コントローラ14、周辺機器15、電源16、外部通信10、圧力送出部11、患者インタフェース17および薬剤送達部19を有する本発明による鎮静・鎮痛システム22の一実施形態のブロック図を示し、ここでは、鎮静・鎮痛システム22は、患者18に鎮静および/または鎮痛を与えるために、ユーザ13によって操作される。鎮静・鎮痛システム22の例は、1999年6月3日に出願され全体として参照により本明細書に援用される米国特許出願第09/324,759号により開示され使用可能にされている。ユーザインタフェース12の実施形態は、2002年11月1日に出願され全体として参照により本明細書に援用される米国特許出願第10/285,689号によって開示され使用可能にされている。
Detailed Description of the Invention
FIG. 1 illustrates one implementation of a sedation and analgesia system 22 according to the present invention having a user interface 12, a software controller 14, a peripheral device 15, a power supply 16, an external communication 10, a pressure delivery unit 11, a patient interface 17 and a drug delivery unit 19. A block diagram of the form is shown, wherein the sedation and analgesia system 22 is operated by the user 13 to provide sedation and / or analgesia to the patient 18. An example of a sedation and analgesia system 22 is disclosed and enabled by US patent application Ser. No. 09 / 324,759 filed Jun. 3, 1999 and incorporated herein by reference in its entirety. Embodiments of the user interface 12 are disclosed and enabled by US patent application Ser. No. 10 / 285,689 filed Nov. 1, 2002, which is incorporated herein by reference in its entirety.

患者インタフェース17は、限定されないが、非侵襲的血圧モニタ、パルスオキシメータ、カプノメータ、ECG、患者意識評価システム、換気流モニタ、換気圧モニタ、インピーダンスプレスチモグラフ(IPG)、ガス分析器、換気温度モニタ、換気湿度モニタおよび聴覚モニタを含む、生命徴候モニタおよび意識モニタ等の1つまたは複数の患者健康状態モニタを含む。患者インタフェース17の患者モニタは、コントローラ14に電子的に結合され、患者の実際の生理学的状態を表す信号を供給してもよい。本発明の一実施形態では、少なくとも1つのモニタは、所定の期間にわたり第1の患者パラメータをモニタし、そこで、患者パラメータの傾向が分析されることにより、よくない患者の状態が切迫しているか否かが判断され、かつ/またはデータがアーティファクトによる可能性があるか、または真の患者の状態を表す可能性があるかが突き止められる。モニタされるパラメータには、たとえば、心拍数、二酸化炭素レベル、酸素飽和度および血圧が含まれてもよい。   The patient interface 17 includes, but is not limited to, a noninvasive blood pressure monitor, pulse oximeter, capnometer, ECG, patient awareness evaluation system, ventilation flow monitor, ventilation pressure monitor, impedance plethysmograph (IPG), gas analyzer, ventilation temperature. Includes one or more patient health monitors such as vital signs monitors and consciousness monitors, including monitors, ventilation and humidity monitors and auditory monitors. A patient monitor at the patient interface 17 may be electronically coupled to the controller 14 to provide signals representative of the actual physiological state of the patient. In one embodiment of the present invention, the at least one monitor monitors the first patient parameter over a predetermined period of time, where the trend of the patient parameter is analyzed to determine whether an unfavorable patient condition is imminent. A determination is made and / or it is determined whether the data may be due to artifacts or may represent a true patient condition. Monitored parameters may include, for example, heart rate, carbon dioxide level, oxygen saturation, and blood pressure.

患者のモニタされたパラメータが所定の安全データセット外になる(たとえば、心拍数が、低すぎるとみなされる値まで低下する)前には、一般に、そのパラメータが最終的に安全データセット閾値を越える低速な変化、すなわち傾向の(たとえば、心拍数がゆっくりと低下する)期間がある。モニタリングシステムは、傾向分析がなければ、一般に、パラメータがその安全データセット外になった時にのみ臨床医に警報を与えることになり、付添い人が、すでに危険な可能性のある状況を是正するようにせかされることになる場合が多い。システム22によって提供される傾向分析により、発現している可能性のある危険な可能性のある状況に対し、臨床医に早期に警報を与えることができる。さらに、患者パラメータがデータアーティファクトのために安全データセット外になると、本発明の傾向分析により、鎮静・鎮痛システム22は、緊迫したよくない患者の状態を示す先行情報がないために、アーティファクトを認識することができる可能性がある。コントローラ14は、患者インタフェース17からの電子フィードバックを、所定の期間にわたってメモリデバイスに格納されたデータと比較してもよく、その場合、かかるデータを、ポイントごとではなく情報の傾向として評価してもよい。   Before a patient's monitored parameter falls outside a predetermined safety data set (eg, the heart rate drops to a value deemed to be too low), the parameter generally exceeds the safety data set threshold eventually. There is a slow change, i.e. a period of trend (e.g. heart rate slowly decreases). Without trend analysis, the monitoring system will generally alert the clinician only when the parameter is outside its safety data set, so that the attendant can correct a potentially dangerous situation. In many cases, you will be slain. The trend analysis provided by the system 22 can provide early alerts to the clinician for potentially dangerous situations that may be present. In addition, when patient parameters fall outside the safety data set due to data artifacts, the trend analysis of the present invention allows the sedation and analgesia system 22 to recognize the artifacts because there is no prior information indicating an impending bad patient condition. There is a possibility that you can. The controller 14 may compare the electronic feedback from the patient interface 17 with data stored in the memory device over a predetermined period of time, in which case the data may be evaluated as a trend of information rather than point by point. Good.

コントローラ14を、傾向分析および/または格納されたデータ比較の結果に応じて作動部(effector)(図示せず)を制御するようにプログラムしてもよい。作動部は、患者の安全性および臨床医の認識を確実にすることができる任意の適当な制御機能であってもよい。作動部は、限定されないが、薬剤減少、薬剤増加、気道陽圧変化、警報、事前警報、酸素送出、モニタからのさらなるデータサンプリングのためのトリガ、たとえば二酸化炭素およびオピオイド拮抗薬への薬剤の変更および患者反応問合せを含む。作動部は、付き添いの臨床医に警報を与えることなく静かに開始してもよく、ユーザインタフェース12によって信号が送られてもよく、かつ/または開始される前にユーザからの確認を必要としてもよい。   The controller 14 may be programmed to control an effector (not shown) in response to the results of trend analysis and / or stored data comparison. The actuator may be any suitable control function that can ensure patient safety and clinician awareness. Actuators include, but are not limited to, drug reduction, drug increase, positive airway pressure change, alarm, advance alarm, oxygen delivery, trigger for further data sampling from the monitor, eg change of drug to carbon dioxide and opioid antagonist And patient response queries. The actuator may begin silently without alerting the attending clinician, may be signaled by the user interface 12, and / or may require confirmation from the user before it is initiated. Good.

図2は、モニタされる患者からの心拍数傾向33を示す表示30の一実施形態を示す。例示する表示では、所与の患者および臨床的情況に対する安全な心拍範囲を、90〜110bpmであるとみなしても良い。傾向33を、心拍数y軸31と時間x軸32とに基づいて確立してもよい。表示30はさらに、患者の心拍数が安全データセット内にあり(95bpm)、臨床医に警報を与えかつ/または患者を安全な状態にする処置をとることのないようにする期間34を示す。期間34に続き、表示30は、傾向33の期間35を示す。期間35は、確立された安全データセットが与えられると、許容可能な心拍数の所定の安全な範囲外になる。しかしながら、よくない患者の状態が存在する根拠となる証拠がなければ、単一のデータポイントのみが90bmp閾値より下になり、ほとんどの真に重大なよくない患者の状態に合致する閾値に向う傾斜した低下がない場合、期間35は、データアーティファクトの結果である可能性がある。例示した例の間に臨床医に警報を与えることにより、誤検出警報がもたらされる可能性があり、そのため、モニタリングシステムの特異性が低下し、付き添いの臨床医がいらだつ可能性がある。誤検出警報が一貫して開始することにより、臨床医は、最終的に真によくない患者の状態を示す可能性のある警報に対してそれほど注意を払わなくなる可能性がある。   FIG. 2 illustrates one embodiment of a display 30 that shows a heart rate trend 33 from the patient being monitored. In the illustrated display, a safe heart rate range for a given patient and clinical situation may be considered 90-110 bpm. A trend 33 may be established based on the heart rate y-axis 31 and the time x-axis 32. The display 30 further shows a period 34 during which the patient's heart rate is in the safety data set (95 bpm), alerting the clinician and / or taking no action to make the patient safe. Following the period 34, the display 30 shows a period 35 of the trend 33. Time period 35 falls outside a predetermined safe range of acceptable heart rate given an established safety data set. However, if there is no evidence to support the existence of a bad patient condition, only a single data point is below the 90 bmp threshold, and a slope towards a threshold that matches most truly serious bad patient conditions If there is no decrease, period 35 may be the result of a data artifact. Alerting the clinician during the illustrated example can result in false alarms, which can reduce the specificity of the monitoring system and frustrate the attending clinician. With false detection alerts consistently initiated, clinicians may end up paying less attention to alerts that may ultimately indicate a really bad patient condition.

図3は、モニタされる患者からの心拍数傾向43を示す表示40のさらなる例を示す。例示する表示では、所与の患者および臨床的情況に対する安全な心拍範囲を、たとえば90〜110bpmであるとみなしてもよい。傾向43を、心拍数y軸41と時間x軸42とに基づいて確立してもよい。表示40はさらに、患者の心拍数が安全データセット内にあり(100bpm)、臨床医に警報を与えかつ/または患者を安全な状態にする処置をとることがないようにする期間44を示す。期間44に続き、表示40は、傾向43の期間45を示す。期間45は、傾向43の下方に傾斜する部分であり、期間45は、最終的に、確立された90bpmの安全閾値を越える。例示する例では、既存のモニタリングシステムは、期間45が最後に90bpm閾値を越えた場合にのみ警報を発した可能性があり、かかる切迫した事象は、傾向の形態研究により早い段階で検出可能であった可能性がある。本明細書でさらに説明するように、本発明は、傾向分析において傾斜変動を検出することにより、かかる切迫したよくない患者の状態を完全に悪化する前に検出することができる可能性があり、それにより、付き添いの臨床医の貴重な時間において患者の安全性を確実にすることができる。さらに、期間45の傾斜に基づき、衰弱する患者の状態を示すかかるデータが、偽のデータからもたらされる可能性が低い。本発明は、鎮静・鎮痛システム22に傾向分析を組み込むことによって、モニタされる患者パラメータの傾向を評価することにより真に重大な患者事象を早い段階で捕らえる一方で、データアーティファクトの影響を低減することにより、患者モニタリングの特異性を向上させることができる可能性がある。   FIG. 3 shows a further example of a display 40 showing a heart rate trend 43 from the patient being monitored. In the illustrated display, a safe heart rate range for a given patient and clinical situation may be considered, for example, 90-110 bpm. A trend 43 may be established based on the heart rate y-axis 41 and the time x-axis 42. The display 40 further shows a period 44 during which the patient's heart rate is in the safety data set (100 bpm) and no action is taken to alert the clinician and / or make the patient safe. Following the period 44, the display 40 shows a period 45 of the trend 43. Period 45 is the downward slope of trend 43, and period 45 eventually exceeds the established 90 bpm safety threshold. In the illustrated example, an existing monitoring system may only have alerted when period 45 has finally exceeded the 90 bpm threshold, and such impending events can be detected earlier by trend morphology studies. There may have been. As described further herein, the present invention may be able to detect such imminent patient conditions before they are completely aggravated by detecting tilt variation in trend analysis, Thereby, patient safety can be ensured in the valuable time of the attending clinician. Furthermore, based on the slope of period 45, such data indicative of a debilitating patient condition is unlikely to come from spurious data. The present invention incorporates trend analysis into the sedation and analgesia system 22 to reduce the impact of data artifacts while capturing truly critical patient events early on by assessing trends in monitored patient parameters. This may improve the specificity of patient monitoring.

図4は、鎮静・鎮痛システム22に傾向分析を組み込む方法100の一実施形態を示す。方法100は、所与の患者パラメータをモニタする患者モニタを提供することを含むステップ101を含む。ステップ101のモニタは、たとえば、心拍数を測定するパルスオキシメータであってもよいが、任意の適当な患者パラメータの任意の適当なモニタも本発明に従う。ステップ102は、ステップ101のモニタにより患者をモニタすることを含み、モニタから収集されたデータを、鎮静・鎮痛システム22(図1)のコントローラ14に送信してもよい。   FIG. 4 illustrates one embodiment of a method 100 for incorporating trend analysis into the sedation and analgesia system 22. The method 100 includes a step 101 that includes providing a patient monitor that monitors a given patient parameter. The monitor of step 101 may be, for example, a pulse oximeter that measures heart rate, but any suitable monitor of any suitable patient parameter is in accordance with the present invention. Step 102 includes monitoring the patient with the monitor of step 101, and data collected from the monitor may be transmitted to the controller 14 of the sedation and analgesia system 22 (FIG. 1).

ステップ103は、ステップ101のモニタから受信されたデータに基づいて傾向を作成することを含む。たとえば、図2および図3は、所定の期間にわたるデータポイントを結合することにより作成された傾向を示す。かかる傾向を、任意の適当な手段によって確立してもよく、かかる傾向をさらに、付き添いの臨床医が視覚的に分析するために表示してもよい。ステップ103に続き、方法100はステップ104および/またはステップ105に進んでもよい。   Step 103 includes creating a trend based on the data received from the monitor of step 101. For example, FIGS. 2 and 3 show trends created by combining data points over a predetermined period of time. Such trends may be established by any suitable means, and such trends may be further displayed for visual analysis by attending clinicians. Following step 103, method 100 may proceed to step 104 and / or step 105.

ステップ104は、ステップ103によって確立された傾向を分析することを含む。たとえば、かかる傾向を、以下の方法で分析してもよい。すなわち、(1)傾向が線形、擬似線形、または単調な性質を有する場合、傾向の傾斜を計算することにより、傾向が安全データセットの外側限界に向かってまったく変わらずに(inexorably)進行しているか否かを判断してもよく、(2)傾向が単一(たとえば、線形)経路を辿る傾向がない場合、傾向変動に対する複数の傾斜を計算することにより、傾向がどこに向かっているように見えるかを突き止めてもよく、(3)傾向が本質的に多項式である場合、多項式の係数を計算することにより、傾向の方向を突き止めてもよく、(4)最小平均2乗誤差技法および他のかかるアルゴリズムを使用して、傾向の曲線あてはめを行い、傾向が安全データセットを越えるか、かついつ越えるかを予測する。かかる分析から、本発明は、真の患者の状態の最も正確な描写を示す方法で任意の適当な患者パラメータの傾向をモニタすることを含む。   Step 104 includes analyzing the trend established by step 103. For example, such a tendency may be analyzed by the following method. (1) If the trend has a linear, quasi-linear, or monotonic nature, calculating the slope of the trend allows the trend to progress inexorably towards the outer limit of the safety data set (2) If the trend does not tend to follow a single (eg, linear) path, it is possible to determine where the trend is by calculating multiple slopes for the trend variation. (3) If the trend is inherently a polynomial, it may determine the direction of the trend by calculating the coefficients of the polynomial, and (4) the least mean square error technique and others Using such an algorithm, trend curve fitting is performed to predict when and when the trend will exceed the safety data set. From such an analysis, the present invention involves monitoring the trend of any suitable patient parameter in a manner that provides the most accurate depiction of the true patient condition.

ステップ104によれば、上記分析に基づき、方法100はその後、確立された安全データセットに対しモニタされた傾向を評価してもよい。たとえば図3を参照すると、傾向45の傾斜が特定の率を越えた場合、かかる傾斜は切迫したよくない患者の状態を示し、鎮静・鎮痛システム22は、本明細書でさらに説明するように、事前警報または他の適当な処置を開始してもよい。ステップ104はさらに、本技術分野において一般に既知である手段により、コントローラ14に提示されるデータが実際に傾斜の変化を示すか否かに対する確率値を計算することを含む。比較分析に基づき、かかるデータが傾斜の変化を反映する場合、鎮静・鎮痛システム22はその後、かかるデータを評価することにより、傾斜が切迫したよくない患者の状態を示すか否かを判断してもよい。さらに、図2を参照すると、かかる分析により、データアーティファクトとしての期間35を切り捨てることができ、それにより、鎮静・鎮痛システム22が誤検出警報を開始する確率が低下する。単一のモニタされた患者パラメータに傾向分析を組み込むことであっても、鎮静・鎮痛システム22の特異性を向上させるのに役立ち(データアーティファクトの影響を低減することにより)、よくない患者の状態の事実をそれらが明白になる前に捕らえるのに役立つ。また、かかる傾向分析を、鎮静・鎮痛システム22のための複数のパラメータに適用してもよく、それによりさらに有利な結果が得られる。   According to step 104, based on the above analysis, the method 100 may then evaluate the monitored trend against the established safety data set. For example, referring to FIG. 3, if the slope of trend 45 exceeds a certain rate, such slope indicates an impending bad patient condition, and sedation and analgesia system 22 is described in further detail herein. A pre-alarm or other suitable treatment may be initiated. Step 104 further includes calculating a probability value for whether the data presented to the controller 14 actually indicates a change in slope by means generally known in the art. Based on a comparative analysis, if such data reflects a change in tilt, the sedation / analgesic system 22 then evaluates such data to determine whether the tilt indicates an impending good patient condition. Also good. Further, referring to FIG. 2, such an analysis allows the period 35 as a data artifact to be truncated, thereby reducing the probability that the sedation / analgesic system 22 will initiate a false alarm. Even incorporating trend analysis into a single monitored patient parameter can help improve the specificity of the sedation and analgesia system 22 (by reducing the impact of data artifacts) and poor patient status Helps capture the facts before they become obvious. Such trend analysis may also be applied to multiple parameters for the sedation and analgesia system 22, thereby providing more advantageous results.

ステップ105は、ステップ103において作成された傾向を鎮静・鎮痛システム22の任意の適当なアルゴリズムに入力することを含む。かかる傾向を、関連する患者パラメータからの複数の他の傾向と結合することにより、データアーティファクトの影響をさらに低減し、かかるセンサフュージョンを組み込むことにより確定的でないデータを明らかにすることができる。さらに、かかる傾向を、直交性のある冗長性の機能として組み込んでもよい。ここで、直交性のある冗長性は、複数のモニタにより単一の患者パラメータを同時にモニタすることを言う。センサフュージョンについては、参照により本明細書に援用される、2003年10月3日に出願された「Systems and Methods for Providing Sensor Fusion」と題する本願と同一の譲受人に譲渡された同時係属米国特許出願においてさらに述べられている。直交性のある冗長なモニタリングは、参照により本明細書に援用される、2003年10月3日に出願された「Methods and Systems for Providing Orthogonally Redundant Monitoring in a Sedation and Analgesia System」と題する本願と同一の譲受人に譲渡された同時係属米国特許出願にさらに述べられている。かかる冗長性に傾向分析を組み込むことにより、見逃し警報状態と誤検出警報状態との両方を開始する確率を低下させることによって、鎮静・鎮痛システム22の特異性および感度をさらに向上させることができる。また、かかる傾向をニューラルネットワークに統合してもよい。ここで、ニューラルネットワークは、複雑なパターンを抽出し、不完全なまたは曖昧な事態(picture)が提示される場合であっても正しい判断に達することができるコンピュータ化知能のシステムである。   Step 105 includes inputting the trend created in step 103 into any suitable algorithm of the sedation and analgesia system 22. By combining such trends with multiple other trends from relevant patient parameters, the effects of data artifacts can be further reduced and non-deterministic data can be revealed by incorporating such sensor fusion. Further, such a tendency may be incorporated as a function of redundancy having orthogonality. Here, orthogonal redundancy refers to simultaneously monitoring a single patient parameter with multiple monitors. For sensor fusion, a co-pending US patent assigned to the same assignee as the present application entitled “Systems and Methods for Providing Sensor Fusion” filed on Oct. 3, 2003, which is incorporated herein by reference. It is further described in the application. Orthogonal and redundant monitoring is identical to the present application entitled “Methods and Systems for Providing Orthogonally Redundant Monitoring in a Sedation and Analgesia System” filed Oct. 3, 2003, which is incorporated herein by reference. Is further described in a co-pending US patent application assigned to the assignee of the present application. By incorporating trend analysis into such redundancy, the specificity and sensitivity of the sedation / analgesic system 22 can be further improved by reducing the probability of initiating both a missed alarm condition and a false alarm condition. Moreover, you may integrate this tendency into a neural network. Here, a neural network is a computerized intelligence system that can extract complex patterns and reach a correct judgment even when an incomplete or ambiguous picture is presented.

本発明は、鎮静・鎮痛システム22に傾向分析を組み込むことを含み、かかる統合により、コントローラ14は、患者の状態に関してより正確にデータを分析することができ得る。所与のパラメータをモニタすることにより、アーティファクトの存在を減少させ切迫したよくない患者事象を予期することが可能になり得るが、単一パラメータの傾向モニタリング、複数の関連するパラメータの傾向モニタリングおよびニューラルネットワークと連携して傾向を使用することにより、鎮静・鎮痛システム22が患者の状態の真の事態に基づいて処置を行う能力がさらに向上する。ステップ105による鎮静・鎮痛システム22に関連するアルゴリズムに基づいて行われる処置には、ステップ106に示す処置とともに、患者の安全性を確実するのに役立つ他の任意の適当な処置が含まれる。   The present invention includes incorporating trend analysis into the sedation and analgesia system 22, and such integration may allow the controller 14 to analyze data more accurately with respect to patient status. Monitoring a given parameter may be able to reduce the presence of artifacts and anticipate imminent bad patient events, but single parameter trend monitoring, trend monitoring of multiple related parameters and neural By using trends in conjunction with the network, the ability of the sedation and analgesia system 22 to perform treatment based on the true state of the patient's condition is further improved. Treatments performed based on the algorithm associated with the sedation and analgesia system 22 at step 105 include, in addition to the treatment shown at step 106, any other suitable treatment that helps to ensure patient safety.

ステップ106は、ステップ104の傾向分析に基づいて適当な処置を行うことを含む。たとえば、傾向分析から、安全データセット外のデータがアーティファクトによる(図2におけるように)と判断された場合、方法100はステップ102に進んでもよく、鎮静・鎮痛システム22は他の処置を行わなくてもよい。データアーティファクトが存在する場合に通常の機能を維持することにより、誤検出警報の確率を低減することができ、鎮静・鎮痛システム22が実際の患者の状態をより直接的にモニタすることができるようになり得る。傾向分析に基づき、よくない患者の症状の発現が切迫している(図3におけるように)と判断された場合、ステップ106は、事前警報を開始することを含む。事前警報は、付き添いの臨床医に対し切迫したよくない患者の状態の確率が高いことを警告するためにとられる任意の適当な処置であってもよい。かかる事前警報は、視覚的にかつ/または音声により通知してもよく、また、たとえば、薬剤レベルを減少させること、薬剤をたとえば二酸化炭素および/またはオピオイド拮抗薬に変更すること、患者モニタからより多くの情報を収集する要求をトリガすること、酸素を送出すること、患者応答性を試験すること、および気道陽圧を送出することが含まれてもよい。かかる処置を、患者が確立された安全閾値を越えた場合に行ってもよく、かかる事象に対する警報は、たとえば、事前警報に関するものより大きいものであってもよい。傾向分析により早い段階で処置をとることにより、鎮静・鎮痛システム22は、臨床医に早い段階で警報を与えることができ、多くのよくない患者の状態をまとめて事前に回避することができる可能性がある。たとえば、心拍数を表す傾向が、心拍数が急激に低下しておりかつアーティファクトによるものではないことを示す場合、鎮静・鎮痛システム22は、患者の心拍数が確立された安全データセット外になる前に薬剤送達を休止させてもよい。かかる事前の処置により、よくない患者の状態が重症になるのを回避しまたはその重症度を低減することができる。   Step 106 includes taking appropriate action based on the trend analysis of step 104. For example, if trend analysis determines that data outside the safety data set is due to artifacts (as in FIG. 2), the method 100 may proceed to step 102 and the sedation and analgesia system 22 will not take any other action. May be. Maintaining normal functionality in the presence of data artifacts can reduce the probability of false alarms and allow the sedation and analgesia system 22 to monitor the actual patient condition more directly. Can be. If, based on the trend analysis, it is determined that bad patient symptoms are imminent (as in FIG. 3), step 106 includes initiating a pre-alarm. The pre-alarm may be any suitable action taken to alert the attending clinician that there is a high probability of an impending bad patient condition. Such pre-alarms may be notified visually and / or audibly and, for example, by reducing the drug level, changing the drug to, for example, carbon dioxide and / or opioid antagonists, from the patient monitor Triggering a request to collect a lot of information, delivering oxygen, testing patient responsiveness, and delivering positive airway pressure may be included. Such treatment may be performed if the patient exceeds an established safety threshold, and the alert for such an event may be greater than for a pre-alarm, for example. By taking action earlier in the trend analysis, the sedation and analgesia system 22 can alert the clinician at an earlier stage and can avoid many bad patient conditions in advance. There is sex. For example, if the trend representing heart rate indicates that the heart rate is dropping sharply and not due to artifacts, the sedation and analgesia system 22 falls outside the established safety data set of the patient's heart rate. Drug delivery may be paused before. Such prior treatment can avoid or reduce the severity of a bad patient condition.

本明細書において本発明の例示的な実施形態を示し説明したが、当業者には、かかる実施形態が単に例として与えられていることが明らかとなろう。当業者には、出願人が本明細書で開示する本発明の範囲から逸脱することなく、多数の実質的でない変形、変更および代用が明らかとなろう。したがって、本発明は、許可されるような特許請求の範囲による精神および範囲によってのみ限定される、ということが意図されている。   While exemplary embodiments of the present invention have been shown and described herein, it will be apparent to those skilled in the art that such embodiments are provided merely as examples. Numerous insubstantial variations, modifications and substitutions will be apparent to those skilled in the art without departing from the scope of the invention disclosed herein by the applicant. Accordingly, it is intended that the invention be limited only by the spirit and scope of the appended claims as permitted.

本発明による鎮静・鎮痛システムの一実施形態を示すブロック図である。1 is a block diagram showing an embodiment of a sedation / analgesic system according to the present invention. 本発明による心拍数傾向表示の一例を示す図である。It is a figure which shows an example of the heart rate tendency display by this invention. 本発明による心拍数傾向表示のさらなる例を示す図である。It is a figure which shows the further example of the heart rate tendency display by this invention. 本発明による鎮静・鎮痛システムに傾向分析を組み込む方法の一実施形態を示す図である。FIG. 4 illustrates one embodiment of a method for incorporating trend analysis into a sedation and analgesia system according to the present invention.

Claims (14)

患者に結合されるようにかつ該患者の生理学的状態を反映する患者パラメータを測定するように適合された少なくとも1つの患者健康状態モニタ装置と、
ユーザインタフェースと、
前記患者に対し1つまたは複数の薬剤を供給する薬剤送達コントローラと、
前記モニタされた患者の生理学的状態のうちの少なくとも1つの安全なパラメータおよび望ましくないパラメータを反映する安全データセットを格納するメモリデバイスと、
前記患者健康状態モニタ、前記ユーザインタフェース、前記薬剤送達コントローラ、および前記メモリデバイスと相互接続され、前記患者パラメータを受け取り該患者パラメータの傾向を分析することによりよくない患者の状態が切迫しているか否かを判断する電子コントローラと、
を具備する鎮静・鎮痛システム。
At least one patient health monitoring device adapted to be coupled to the patient and to measure patient parameters reflecting the physiological state of the patient;
A user interface;
A drug delivery controller for supplying one or more drugs to the patient;
A memory device storing a safety data set reflecting at least one safe parameter and an undesirable parameter of the monitored patient's physiological condition;
Interconnected with the patient health monitor, the user interface, the drug delivery controller, and the memory device to determine whether an unhealthy patient condition is imminent by receiving the patient parameters and analyzing the patient parameter trends An electronic controller to determine whether
A sedation / analgesic system.
患者の安全性と臨床医の認識とを確実にする1つまたは複数の作動部をさらに具備し、前記電子コントローラは、該作動部と相互接続され、かつ前記患者パラメータの前記傾向に従って該作動部を制御する、請求項1に記載の鎮静・鎮痛システム。   One or more actuators for ensuring patient safety and clinician awareness, wherein the electronic controller is interconnected with the actuators and the actuators according to the trends of the patient parameters The sedation / analgesic system according to claim 1, wherein the sedation and analgesia system is controlled. 前記電子コントローラは、前記安全データセットの範囲内にある前記患者パラメータのよくない傾向に応じて早期の警報を提供する、請求項1に記載の鎮静・鎮痛システム。   The sedation and analgesia system according to claim 1, wherein the electronic controller provides an early warning in response to a bad trend of the patient parameters within the safety data set. 前記電子コントローラは、前記傾向に対し前記患者パラメータ測定値を評価する、請求項1に記載の鎮静・鎮痛システム。   The sedation / analgesic system of claim 1, wherein the electronic controller evaluates the patient parameter measurements against the trend. 前記患者パラメータは、カプノメトリ、パルスオキシメトリおよび血圧から導出されるものである、請求項1に記載の鎮静・鎮痛システム。   The sedation / analgesic system according to claim 1, wherein the patient parameter is derived from capnometry, pulse oximetry and blood pressure. 前記患者パラメータは心拍数である、請求項1に記載の鎮静・鎮痛システム。   The sedation / analgesic system according to claim 1, wherein the patient parameter is a heart rate. 前記少なくとも1つの患者健康状態モニタは、心電計とパルスオキシメータとのうちの一方である、請求項1に記載の鎮静・鎮痛システム。   The sedation / analgesic system according to claim 1, wherein the at least one patient health monitor is one of an electrocardiograph and a pulse oximeter. 鎮静・鎮痛システムに傾向分析を組み込む方法であって、
単一患者パラメータをモニタする患者に対する患者モニタを提供するステップと、
該モニタによって前記患者をモニタするステップであって、該モニタから収集されたデータを、前記鎮静・鎮痛システムのコントローラに送信してもよい、モニタするステップと、
前記モニタから受信されたデータに基づいて傾向を作成するステップと、
該傾向を前記鎮静・鎮痛システムのアルゴリズムに入力するステップと該傾向を分析するステップとのうちの少なくとも一方と、
前記傾向分析に基づき適当な処置を開始するステップと、
を含む鎮静・鎮痛システムに傾向分析を組み込む方法。
A method of incorporating trend analysis into a sedation and analgesia system,
Providing a patient monitor for a patient monitoring single patient parameters;
Monitoring the patient with the monitor, wherein the data collected from the monitor may be sent to a controller of the sedation and analgesia system;
Creating a trend based on data received from the monitor;
At least one of a step of inputting the trend to the algorithm of the sedation / analgesic system and a step of analyzing the trend;
Starting appropriate treatment based on the trend analysis;
To incorporate trend analysis into sedation and analgesia systems.
前記分析するステップは、前記傾向の傾斜を計算すること、傾向変動に対する複数の傾斜を計算すること、多項式の係数を計算すること、および最小平均2乗誤差技法を使用して前記傾斜の曲線あてはめを行うことのうちの少なくとも1つを含む、請求項8に記載の鎮静・鎮痛システムに傾向分析を組み込む方法。   The analyzing step includes calculating a slope of the trend, calculating a plurality of slopes for trend variation, calculating a coefficient of a polynomial, and curve fitting of the slope using a minimum mean square error technique. 9. A method of incorporating trend analysis into a sedation and analgesia system according to claim 8, comprising at least one of: 前記コントローラに提示されるデータが実際に傾斜の変化を示すか否かに対する確率値を計算するステップをさらに含む、請求項8に記載の鎮静・鎮痛システムに傾向分析を組み込む方法。   9. The method of incorporating trend analysis into a sedation and analgesia system according to claim 8, further comprising calculating a probability value for whether the data presented to the controller actually indicates a change in slope. 前記傾向を、関連する患者パラメータからの複数の他の傾向と組み合わせて分析する、請求項8に記載の鎮静・鎮痛システムに傾向分析を組み込む方法。   9. The method of incorporating trend analysis into a sedation and analgesia system according to claim 8, wherein the trend is analyzed in combination with a plurality of other trends from associated patient parameters. 前記傾向を、直交性のある冗長性の機能として組み込む、請求項9に記載の鎮静・鎮痛システムに傾向分析を組み込む方法。   10. The method of incorporating trend analysis into a sedation and analgesia system according to claim 9, wherein the trend is incorporated as a function of orthogonal redundancy. 前記傾向を、少なくとも1つのニューラルネットワークに統合する、請求項8に記載の鎮静・鎮痛システムに傾向分析を組み込む方法。   9. The method of incorporating trend analysis into a sedation and analgesia system according to claim 8, wherein the trend is integrated into at least one neural network. 前記適当な処置は、モニタし続けること、事前警報を開始すること、薬剤送達を休止すること、および完全な警報を開始することのうちの少なくとも1つを含む、請求項8に記載の鎮静・鎮痛システムに傾向分析を組み込む方法。
9. The sedation according to claim 8, wherein the appropriate treatment includes at least one of continuing monitoring, initiating a pre-alarm, pausing drug delivery, and initiating a full alarm. How to incorporate trend analysis into an analgesic system.
JP2004541700A 2002-10-03 2003-10-03 System and method for trend analysis in sedation and analgesia systems Pending JP2006503617A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41552402P 2002-10-03 2002-10-03
PCT/US2003/031685 WO2004030525A2 (en) 2002-10-03 2003-10-03 Systems and methods for providing trend analysis in a sedation and analgesia system

Publications (2)

Publication Number Publication Date
JP2006503617A true JP2006503617A (en) 2006-02-02
JP2006503617A5 JP2006503617A5 (en) 2006-09-28

Family

ID=32069875

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004541700A Pending JP2006503617A (en) 2002-10-03 2003-10-03 System and method for trend analysis in sedation and analgesia systems

Country Status (7)

Country Link
US (1) US8028694B2 (en)
EP (1) EP1554003A4 (en)
JP (1) JP2006503617A (en)
CN (1) CN100563744C (en)
AU (2) AU2003275460A1 (en)
CA (1) CA2507488A1 (en)
WO (1) WO2004030525A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016520821A (en) * 2013-04-29 2016-07-14 フラウンホファー‐ゲゼルシャフト・ツア・フェルデルング・デア・アンゲヴァンテン・フォルシュング・エー・ファウ Noninvasive methods to predict opioid analgesia and opioid blood levels

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10173008B2 (en) 2002-01-29 2019-01-08 Baxter International Inc. System and method for communicating with a dialysis machine through a network
BR0308878A (en) * 2002-04-01 2005-01-04 Aspect Medical Systems Inc System and method for assessing arousal and tension during anesthesia and sedation
US20040116969A1 (en) * 2002-08-26 2004-06-17 Owen James M. Pulse detection using patient physiological signals
US7827983B2 (en) 2004-12-20 2010-11-09 Hewlett-Packard Development Company, L.P. Method for making a pharmaceutically active ingredient abuse-prevention device
US8574156B2 (en) * 2005-07-05 2013-11-05 General Electric Company Determination of the clinical state of a subject
DE102006045014A1 (en) 2006-09-23 2008-04-03 Dräger Medical AG & Co. KG Method and device for monitoring a dosage of at least one drug
DE102007038915A1 (en) 2006-11-14 2008-05-15 Dräger Medical AG & Co. KG Patient parameter e.g. anesthetic concentration, monitoring method for anesthesia device, involves selecting parameter region, which is based on region between pharmacodynamical effects or region between levels of pharmacodynamical effects
US10089443B2 (en) 2012-05-15 2018-10-02 Baxter International Inc. Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US8968193B2 (en) * 2008-09-30 2015-03-03 Covidien Lp System and method for enabling a research mode on physiological monitors
US8554579B2 (en) 2008-10-13 2013-10-08 Fht, Inc. Management, reporting and benchmarking of medication preparation
DE102009013396B3 (en) 2009-03-16 2010-08-05 Dräger Medical AG & Co. KG Apparatus and method for controlling the oxygen dosage of a ventilator
US8412295B2 (en) * 2009-03-31 2013-04-02 Covidien Lp Systems and methods for monitoring pain management
US8814791B2 (en) * 2009-03-31 2014-08-26 Nellcor Puritan Bennett Ireland Systems and methods for monitoring pain management
US8858433B2 (en) * 2009-03-31 2014-10-14 Nellcor Puritan Bennett Ireland Systems and methods for monitoring pain management
US8417308B2 (en) * 2009-03-31 2013-04-09 Covidien Lp Systems and methods for monitoring pain management
US8577433B2 (en) * 2009-11-18 2013-11-05 Covidien Lp Medical device alarm modeling
US8695591B2 (en) 2010-05-26 2014-04-15 Lloyd Verner Olson Apparatus and method of monitoring and responding to respiratory depression
US8374666B2 (en) 2010-05-28 2013-02-12 Covidien Lp Retinopathy of prematurity determination and alarm system
US8428677B2 (en) 2010-05-28 2013-04-23 Covidien Lp Retinopathy of prematurity determination and alarm system
WO2011159972A2 (en) * 2010-06-17 2011-12-22 Welch Allyn, Inc. Detection of noise during heart beat variation evaluation
US8717181B2 (en) 2010-07-29 2014-05-06 Hill-Rom Services, Inc. Bed exit alert silence with automatic re-enable
US9092559B2 (en) 2011-08-16 2015-07-28 Ethicon Endo-Surgery, Inc. Drug delivery system with open architectural framework
WO2014059418A1 (en) * 2012-10-12 2014-04-17 The General Hospital Corporation System and method for monitoring and controlling a state of a patient during and after administration of anesthetic compound
CA2889352C (en) 2012-10-26 2021-12-07 Baxter Corporation Englewood Improved work station for medical dose preparation system
CA2889210C (en) 2012-10-26 2020-12-15 Baxter Corporation Englewood Improved image acquisition for medical dose preparation system
JP6824608B2 (en) * 2013-03-16 2021-02-03 エンパティカ エスアールエル Equipment for measuring skin electrical activity with current compensation
EP2989569B1 (en) 2013-04-24 2021-06-23 Fresenius Kabi Deutschland GmbH Method of operating a control device for controlling an infusion device
US11107574B2 (en) 2014-09-30 2021-08-31 Baxter Corporation Englewood Management of medication preparation with formulary management
AU2015358483A1 (en) 2014-12-05 2017-06-15 Baxter Corporation Englewood Dose preparation data analytics
EP3265989A4 (en) 2015-03-03 2018-10-24 Baxter Corporation Englewood Pharmacy workflow management with integrated alerts
AU2018248113A1 (en) 2017-04-05 2019-10-31 Fisher & Paykel Healthcare Limited Flow therapy system and method
US11375896B2 (en) 2017-08-18 2022-07-05 Megan Reinhardt Edge-intelligent iot-based wearable device for detection of cravings in individuals
US10478066B2 (en) * 2017-08-18 2019-11-19 Megan Reinhardt System and method for detection of cravings in individuals with addiction
US10380249B2 (en) * 2017-10-02 2019-08-13 Facebook, Inc. Predicting future trending topics
CN109199347B (en) * 2018-08-23 2021-09-17 江苏人先医疗科技有限公司 Ward terminal and computer readable storage medium for analgesia monitoring
CN113380411B (en) * 2021-07-19 2024-03-01 苏州百孝医疗科技有限公司 Method for improving accuracy of concentration change real-time trend in continuous monitoring process of animal analyte concentration

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10248934A (en) * 1997-03-10 1998-09-22 Michael Dr Georgieff Apparatus for controlled anesthesia, pain killing and sedation
JP2002516692A (en) * 1998-06-03 2002-06-11 スコット・ラボラトリーズ・インコーポレイテッド Apparatus and method for relieving conscious patient from pain and anxiety associated with medical or surgical procedures

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1176476A (en) * 1913-07-28 1916-03-21 Splitdorf Electrical Co Ignition-dynamo.
BE428090A (en) * 1937-05-31
US2185068A (en) * 1937-12-10 1939-12-26 Ohio Chemical And Mfg Company Apparatus for self-administration of anesthetics
US2690178A (en) * 1950-11-13 1954-09-28 Research Corp Automatic apparatus for administering drugs
US2888922A (en) * 1954-08-17 1959-06-02 Bellville John Weldon Continuous servo-medicator
US3143111A (en) * 1960-09-23 1964-08-04 Winston Electronics Ltd Blood pressure follower
US3651806A (en) * 1969-10-24 1972-03-28 Philip I Hirshberg Method and apparatus for administering digitalizing medications
US3762398A (en) * 1972-01-03 1973-10-02 J Schefke Mobile and flexible intensive care unit
US3898983A (en) * 1973-10-03 1975-08-12 James O Elam Device and method for detecting the degree of muscle relaxation of a medical patient
US4080966A (en) * 1976-08-12 1978-03-28 Trustees Of The University Of Pennsylvania Automated infusion apparatus for blood pressure control and method
US4078562A (en) * 1976-08-16 1978-03-14 Diana W. Friedman Infusion pump with feedback control
US4148312A (en) * 1976-10-08 1979-04-10 Minnesota Mining And Manufacturing Company Combination anesthesia and intensive care apparatus
US4308866A (en) * 1978-11-02 1982-01-05 University Of Southern California Infusion controlling apparatus and method
US4731051A (en) * 1979-04-27 1988-03-15 The Johns Hopkins University Programmable control means for providing safe and controlled medication infusion
US4280494A (en) * 1979-06-26 1981-07-28 Cosgrove Robert J Jun System for automatic feedback-controlled administration of drugs
US4533346A (en) * 1979-06-26 1985-08-06 Pharmacontrol Corporation System for automatic feedback-controlled administration of drugs
US4275727A (en) * 1980-01-07 1981-06-30 Keeri Szanto Michael Device for monitoring and controlling self-administered intravenous drug dosage
US4392849A (en) * 1981-07-27 1983-07-12 The Cleveland Clinic Foundation Infusion pump controller
JPS58135043A (en) * 1982-02-04 1983-08-11 Laurel Bank Mach Co Ltd Automatic cash dispenser
US4550726A (en) * 1982-07-15 1985-11-05 Mcewen James A Method and apparatus for detection of breathing gas interruptions
US4610254A (en) * 1984-03-08 1986-09-09 Physio-Control Corporation Interactive portable defibrillator
US4551133A (en) * 1984-04-16 1985-11-05 American Hospital Supply Corporation Patient controlled medication infusion system
US4718891A (en) * 1984-05-03 1988-01-12 Henry Ford Hospital Automated hemodialysis control based upon patient blood pressure and heart rate
CA1254091A (en) * 1984-09-28 1989-05-16 Vladimir Feingold Implantable medication infusion system
US4634426A (en) * 1984-12-11 1987-01-06 Baxter Travenol Laboratories Medical infusion controller and user interface
DE3501095A1 (en) * 1985-01-15 1986-07-17 Gerd Prof. Dr. 8520 Erlangen Kobal METHOD FOR MEASURING SENSORY QUALITIES AND DEVICE FOR IMPLEMENTING THE METHOD
US5088981A (en) * 1985-01-18 1992-02-18 Howson David C Safety enhanced device and method for effecting application of a therapeutic agent
US4756706A (en) * 1985-01-23 1988-07-12 American Hospital Supply Corporation Centrally managed modular infusion pump system
US4942544A (en) * 1985-02-19 1990-07-17 Kenneth B. McIntosh Medication clock
US4688577A (en) * 1986-02-10 1987-08-25 Bro William J Apparatus for and method of monitoring and controlling body-function parameters during intracranial observation
US5108363A (en) * 1988-02-19 1992-04-28 Gensia Pharmaceuticals, Inc. Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
US5258906A (en) * 1988-07-13 1993-11-02 Vital Heart Systems, Inc. System for remotely authorizing operation of a device and for automatically generating an invoice based on device usage
US5094235A (en) * 1989-05-10 1992-03-10 Dragerwerk Aktiengesellschaft Anesthesia ventilating apparatus having a breathing circuit and control loops for anesthetic gas components
US5065315A (en) * 1989-10-24 1991-11-12 Garcia Angela M System and method for scheduling and reporting patient related services including prioritizing services
US5254087A (en) * 1990-01-29 1993-10-19 Ivra Systems, Inc. Tourniquet apparatus for intravenous regional anesthesia
US5046491A (en) * 1990-03-27 1991-09-10 Derrick Steven J Apparatus and method for respired gas collection and analysis
US5677290A (en) * 1990-05-10 1997-10-14 Fukunaga; Atsuo F. Therapeutic use of adenosine compounds as surgical anesthetics
US5231981A (en) * 1991-03-20 1993-08-03 N.A.D., Inc. Display panel with pistol grip for use with anesthesia apparatus
JPH04309362A (en) 1991-04-08 1992-10-30 Fukuda Denshi Co Ltd infusion system
US5183038A (en) * 1991-11-04 1993-02-02 The Trustees Of The University Of Pennsylvania Gated programmable ventilator
US5253645A (en) * 1991-12-13 1993-10-19 Critikon, Inc. Method of producing an audible alarm in a blood pressure and pulse oximeter monitor
WO1993012828A1 (en) * 1991-12-20 1993-07-08 Abbott Laboratories Drug channel identification and security system for infusion and pumping systems
IL104365A0 (en) * 1992-01-31 1993-05-13 Gensia Pharma Method and apparatus for closed loop drug delivery
US5462698A (en) * 1992-03-03 1995-10-31 Tokuyama Corporation Photochromic composition
US5262944A (en) * 1992-05-15 1993-11-16 Hewlett-Packard Company Method for use of color and selective highlighting to indicate patient critical events in a centralized patient monitoring system
US7081095B2 (en) * 2001-05-17 2006-07-25 Lynn Lawrence A Centralized hospital monitoring system for automatically detecting upper airway instability and for preventing and aborting adverse drug reactions
US5507277A (en) * 1993-01-29 1996-04-16 Aradigm Corporation Lockout device for controlled release of drug from patient-activateddispenser
US5558638A (en) * 1993-04-30 1996-09-24 Healthdyne, Inc. Patient monitor and support system
US5882338A (en) * 1993-05-04 1999-03-16 Zeneca Limited Syringes and syringe pumps
DE4329898A1 (en) * 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5438983A (en) * 1993-09-13 1995-08-08 Hewlett-Packard Company Patient alarm detection using trend vector analysis
US5724025A (en) * 1993-10-21 1998-03-03 Tavori; Itzchak Portable vital signs monitor
US5630710A (en) * 1994-03-09 1997-05-20 Baxter International Inc. Ambulatory infusion pump
US5555891A (en) * 1994-05-20 1996-09-17 Hartford Hospital Vibrotactile stimulator system for detecting and interrupting apnea in infants
US5432698A (en) 1994-05-31 1995-07-11 Modular Instruments, Inc. Data input and output controller for anesthesia monitoring system
US5522798A (en) * 1994-10-17 1996-06-04 Abbott Laboratories Control of a multi-channel drug infusion pump using a pharmacokinetic model
GB9422082D0 (en) * 1994-11-02 1994-12-21 Zeneca Ltd Reservoirs and delivery devices
US5795327A (en) * 1995-03-06 1998-08-18 Sabratek Corporation Infusion pump with historical data recording
US5713856A (en) * 1995-03-13 1998-02-03 Alaris Medical Systems, Inc. Modular patient care system
US5598838A (en) * 1995-04-07 1997-02-04 Healthdyne Technologies, Inc. Pressure support ventilatory assist system
US5730140A (en) * 1995-04-28 1998-03-24 Fitch; William Tecumseh S. Sonification system using synthesized realistic body sounds modified by other medically-important variables for physiological monitoring
US5718223A (en) * 1995-05-16 1998-02-17 Protas; Kenneth S. Anesthesia delivery system
US5614887A (en) * 1995-06-07 1997-03-25 Buchbinder; Dale Patient monitoring system and method thereof
US6165154A (en) * 1995-06-07 2000-12-26 Deka Products Limited Partnership Cassette for intravenous-line flow-control system
US5676133A (en) * 1995-06-14 1997-10-14 Apotheus Laboratories, Inc. Expiratory scavenging method and apparatus and oxygen control system for post anesthesia care patients
US5722956A (en) 1995-08-24 1998-03-03 The General Hospital Corporation Multi-dose syringe driver
US5795301A (en) * 1995-08-31 1998-08-18 Seiko Epson Corporation Display method used in portable pulse measuring device
US5653739A (en) * 1995-09-13 1997-08-05 Empi, Inc. Electronic pain feedback system and method
US6158432A (en) * 1995-12-08 2000-12-12 Cardiopulmonary Corporation Ventilator control system and method
US6148814A (en) * 1996-02-08 2000-11-21 Ihc Health Services, Inc Method and system for patient monitoring and respiratory assistance control through mechanical ventilation by the use of deterministic protocols
BE1010264A5 (en) 1996-03-18 1998-04-07 Struys Michel Device for checking a intravenous injection.
US6182667B1 (en) * 1996-06-21 2001-02-06 Integrated Medical Systems, Inc. Display for transportable life support system
JPH1071137A (en) 1996-08-29 1998-03-17 Omron Corp Device and method for displaying degree of stress
US6165151A (en) * 1996-09-03 2000-12-26 Weiner; Daniel L. Apparatus and methods for control of intravenous sedation
GB9618998D0 (en) 1996-09-11 1996-10-23 Univ Glasgow Anaesthesia control
US5957885A (en) * 1996-11-06 1999-09-28 Alaris Medical Systems, Inc. Oximetry monitored, patient controlled analgesia system
US6062216A (en) * 1996-12-27 2000-05-16 Children's Medical Center Corporation Sleep apnea detector system
DE19709704C2 (en) * 1997-03-10 1999-11-04 Michael Georgieff Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia
US5915379A (en) * 1997-03-14 1999-06-29 Nellcor Puritan Bennett Incorporated Graphic user interface for a patient ventilator
US5873369A (en) * 1997-03-31 1999-02-23 Chronoslim P.C.E. Ltd. System for monitoring health conditions of an individual and a method thereof
US6186977B1 (en) * 1997-04-24 2001-02-13 Joseph L. Riley Anesthesia Associates Apparatus and method for total intravenous anesthesia delivery and associated patient monitoring
US5954050A (en) * 1997-10-20 1999-09-21 Christopher; Kent L. System for monitoring and treating sleep disorders using a transtracheal catheter
US6099481A (en) * 1997-11-03 2000-08-08 Ntc Technology, Inc. Respiratory profile parameter determination method and apparatus
SE9704663D0 (en) * 1997-12-15 1997-12-15 Siemens Elema Ab Fan system
US6152130A (en) * 1998-06-12 2000-11-28 Microdose Technologies, Inc. Inhalation device with acoustic control
US6398727B1 (en) * 1998-12-23 2002-06-04 Baxter International Inc. Method and apparatus for providing patient care
US6302844B1 (en) * 1999-03-31 2001-10-16 Walker Digital, Llc Patient care delivery system
JP2003530937A (en) * 2000-04-25 2003-10-21 インビテック−ウィズマール ゲーエムベーハー Method and apparatus for determining the partial pressure of a gas component in a patient's breath per breath
US6757558B2 (en) * 2000-07-06 2004-06-29 Algodyne, Ltd. Objective pain measurement system and method
AU2003282489A1 (en) * 2002-10-03 2004-04-23 Scott Laboratories, Inc. Bite block apparatus and method for use with a sedation an analgesia system
JP2006501899A (en) * 2002-10-03 2006-01-19 スコット・ラボラトリーズ・インコーポレイテッド System and method for providing sensor fusion
US20040133187A1 (en) * 2002-10-03 2004-07-08 Scott Laboratories, Inc. Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system
US7089927B2 (en) * 2002-10-23 2006-08-15 New York University System and method for guidance of anesthesia, analgesia and amnesia

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10248934A (en) * 1997-03-10 1998-09-22 Michael Dr Georgieff Apparatus for controlled anesthesia, pain killing and sedation
JP2002516692A (en) * 1998-06-03 2002-06-11 スコット・ラボラトリーズ・インコーポレイテッド Apparatus and method for relieving conscious patient from pain and anxiety associated with medical or surgical procedures

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016520821A (en) * 2013-04-29 2016-07-14 フラウンホファー‐ゲゼルシャフト・ツア・フェルデルング・デア・アンゲヴァンテン・フォルシュング・エー・ファウ Noninvasive methods to predict opioid analgesia and opioid blood levels

Also Published As

Publication number Publication date
WO2004030525A8 (en) 2004-08-26
WO2004030525A3 (en) 2004-08-05
WO2004030525A2 (en) 2004-04-15
US20050039742A1 (en) 2005-02-24
AU2003275460A1 (en) 2004-04-23
CN1720074A (en) 2006-01-11
AU2009213027A1 (en) 2009-10-08
EP1554003A4 (en) 2011-10-12
CN100563744C (en) 2009-12-02
EP1554003A2 (en) 2005-07-20
CA2507488A1 (en) 2004-04-15
US8028694B2 (en) 2011-10-04

Similar Documents

Publication Publication Date Title
JP2006503617A (en) System and method for trend analysis in sedation and analgesia systems
US11937949B2 (en) Physiological parameter system
US7539537B2 (en) Systems and methods for providing sensor fusion
US7034692B2 (en) System and method for transparent early detection, warning, and intervention during a medical procedure
JP6066784B2 (en) MEDICAL DEVICE MEASUREMENT INFORMATION MONITOR DEVICE AND MEDICAL DEVICE MEASUREMENT INFORMATION MONITOR SYSTEM
JP2006503617A5 (en)
US20090289799A1 (en) Medical monitoring method and system
CN103800002A (en) Biological information displaying apparatus and biological information displaying system
CA2504874C (en) Methods and systems for providing orthogonally redundant monitoring in a sedation and analgesia system
WO2018064448A1 (en) Patient monitoring system and method configured to suppress an alarm
JP2003225216A (en) Portable type electrocardiograph

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060811

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060811

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090727

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090811

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091110

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091211

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091218

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100112

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100212

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100817

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110201